FrancophonIA/ELRC3.0 huggingface dataset:
English: Masitinib 50 mg
Maltese: TAS-SUSTANZA(I) ATTIVA(I) Masitinib 50 mg
English: Marketing authorisation holder:
Maltese: Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
English: Film coated tablet
Maltese: Numru ta' pilloli kuljum
English: Anaemia due to lack of regeneration, i.e. haemoglobin< 10 g/dl and reticulocytes < 80,000/mm
Maltese: ULN u haptoglobina<0.1g/dl jew retikuloċiti<80,000/mm
English: AB Science S.A.
Maltese: U SUSTANZI OĦRA
English: MASIVET 50 mg film-coated tablets for dogs MASIVET 150 mg film-coated tablets for dogs
Maltese: VETERINARJU MASIVET 50 mg pilloli miksijin b'rita għall-klieb MASIVET 150 mg pilloli miksijin b'rita għall-klieb
English: Your veterinarian can best describe these for you.
Maltese: Il-veterinarju tiegħek jista' jfissirhomlok aħjar.
English: Albumin < 0.75 LLN or UPC > 2
Maltese: Albumina < 0.75
English: Do not use in dogs suffering from liver impairment, defined as AST or ALT > 3 x Upper Limit of Normal (ULN).
Maltese: M'għandux jintuża fi klieb li jbatu minn indeboliment fil-fwied, definit bħala AST jew ALT > 3 x Limitu ta' Fuq tan-Normal (ULN).
English: Duration of treatment depends on the response to treatment.
Maltese: ULN, it-trattament għandu jitwaqqaf.
English: Treatment of non-resectable dog mast cell tumours (Grade 2 or 3) with confirmed mutated c-kit tyrosine kinase receptor.
Maltese: Trattament ta' tumuri tal-mast cell (Grad 2 jew 3) fil-klieb u li ma jistgħux jitneħħew, b'riċettur mibdul ikkonfermat tal-c-KIT tyrosine kinase.
English: 3 avenue George V 75008 Paris
Maltese: AB Science S.A. 3 avenue George V 75008 Paris Franza
English: < 2,000/mm nd rd time)
Maltese: < 2000 /mm (l-ewwel darba)
English: Protein-loss syndrome (mainly due to a decrease in serum albumin).
Maltese: Sindrome tat-telf ta' proteina (l-aktar minħabba tnaqqis tal-albumina fis-serum).
English: The recommended dose is 12.5 mg/kg (with a dose range of 11-14 mg/kg) once daily as presented in the table below.
Maltese: Id-doża rakkomandata hija 12.5 mg/kg (b'medda ta' dożi ta' 11-14 mg/kg) darba kuljum kif muri fittabella hawn taħt.
English: • Increase in aminotransferase (ALT or AST) with a mean duration of approximately 29 days.
Maltese: • Żieda fl-aminotransferase (ALT jew AST) li ddum medja ta' madwar 29 ġurnata.
English: MASIVET 150 mg film-coated tablets for dogs Masitinib
Maltese: VETERINARJU MASIVET 150 mg pilloli miksijin b'rita għall-klieb.
English: Moderate to severe anaemia (aplastic/haemolytic) with a mean duration of approximately 7 days.
Maltese: Anemija moderata għal severa (aplastika/emolitika) li ddum medja ta' 7 ijiem.
English: In dogs with a bodyweight of less than 15 kg, accurate dosing is not always possible.
Maltese: Fi klieb li jiżnu inqas minn 15-il kilogramm, mhuwiex dejjem possibbli dożaġġ preċiż.
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED
Maltese: DATA TA' META ĠIET RIVEDUTA
English: In case of UPC ratio > 2 or albumin < 0.75 lower limit of normal (LLN), treatment should be interrupted until albumin and UPC values have returned to limit value (UPC ratio < 2 and albumin > 0.75 LLN), treatment can then be continued at the same dose.
Maltese: Jekk il-proporzjon tal-UPC ikun > 2 jew l-albumina tkun < 0.75 l-limitu ta' taħt tan-normal (LLN), it-trattament għandu jiġi interrott sakemm il-valuri tal-albumina u tal-UPC ikunu reġgħu lura għall-valur tal-limitu (proporzjon UPC < 2 u albumina > 0.75
English: Long term treatment should be under regular (at least monthly) veterinary control.
Maltese: It-trattament fit-tul għandu jkun taħt kontroll veterinarju regolari (mill-anqas darba fix-xahar).
English: Response to treatment with masitinib was expressed as stable disease; i.e. static, partial or complete response.
Maltese: Irrispons għat-trattament b'masitinib kien imfisser bħala marda stabbli; jiġifieri rispons statiku, parzjali jew komplet.
English: Masivet is a prescription medicine used to treat dog mast cell tumours.
Maltese: Masivet huwa mediċina bir-riċetta li tintuża għat-trattament ta' tumuri tal-mast cell fil-klieb.
English: Following oral administration in dogs at a dose of 11.2 mg (±0.5 mg) per kg of bodyweight, masitinib is rapidly absorbed and the time to maximal concentration (Tmax) is approximately 2 hours.
Maltese: Wara għoti orali fil-klieb b'doża ta' 11.2 mg (±0.5 mg) għal kull kilogramm ta' piż tal-ġisem, masitinib jiġi assorbit malajr u l-ħin għall-konċentrazzjoni massima (Tmax) huwa ta' madwar sagħtejn.
English: < 2,000/mm st time)
Maltese: < 2000 / mm (it-tieni/tielet darba)
English: th time)
Maltese: U KWANTITATTIVA
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Maltese: PARIR GĦALL-AMMINISTRAZZJONI KORRETTA
English: MASIVET 50 mg film-coated tablets for dogs Masitinib
Maltese: VETERINARJU MASIVET 50 mg pilloli miksijin b'rita għall-klieb.
English: • Protein-loss syndrome (mainly due to a decrease in serum albumin).
Maltese: • Is-sindromu tat-telf ta' proteina (l-aktar minħabba tnaqqis tal-albumina fis-serum).
English: i.e. free bilirubin > 1.5 ULN and haptoglobin < 0.1 g/dl,
Maltese: Emoglobina < 10g/dL u jew bilirubina libera > 1.5
English: Treatment should be discontinued in case of:
Maltese: It-trattament għandu jitwaqqaf fil-każ ta':
English: MASIVET is a light-orange, round, film-coated tablet.
Maltese: MASIVET hija pillola ta' lewn oranġjo ċar, tonda, miksija b'rita.
English: 12.5 mg/kg bw Number of tablets per day
Maltese: 12.5 mg/kg piż tal-ġisem
English: Mild or moderate neutropenia with a mean duration of approximately 24 days.
Maltese: Newtropenija ħafifa għal moderata li ddum medja ta' madwar 24 jum.
English: CLINICAL PARTICULARS 4.1 Target species
Maltese: 4.5 Prekawzjonijiet speċjali għall-użu
English: 12.1 Special precautions for use: Special warnings:
Maltese: 12.1 Prekawzjonijiet speċjali għall-użu:
English: The efficacy of Masivet might be reduced in dogs previously treated with chemotherapy and/or radiotherapy.
Maltese: L-effikaċja ta' Masivet tista' tkun imnaqqsa fi klieb ittrattati qabel bil-kemjoterapija u/jew birradjuterapija.
English: Concurrent use of substances which are metabolised by CYP450 isoforms may result in higher or lower plasma levels of either masitinib or those substances.
Maltese: L-użu simultanju ta' sustanzi li jiġu metabolizzati minn isoformi CYP450 jista' jirriżulta f'livelli iżjed għoljin jew iżjed baxxi fil-plażma ta' masitinib jew ta' dawk is-sustanzi.
English: Masivet is for the treatment of dogs with non-resectable mast cell tumours (Grade 2 or 3) with a confirmed mutated c-kit tyrosine kinase receptor.
Maltese: Masivet jintuża għat-trattament ta' klieb li jkollhom tumuri tal-mast cell (Grad 2 jew 3) li ma jistgħux jitneħħew, b'riċettur mibdul ikkonfermat tal-c-KIT tyrosine kinase.
English: In case of adverse reactions, your veterinarian may decide to reduce the dose or to discontinue treatment.
Maltese: F'każ ta' reazzjonijiet avversi, il-veterinarju tiegħek jista' jiddeċiedi li jnaqqas id-doża jew iwaqqaf it-trattament.
English: Pregabalin Accord is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription.
Maltese: Pregabalin Accord jiġi bħala kapsuli (ta' 25, 50, 75, 100, 150, 200, 225 u 300 mg) u jista' jinkiseb biss b'riċetta ta' tabib.
English: The full EPAR for Pregabalin Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The active substance in Pregabalin Accord, pregabalin, is similar in structure to the body's own ‘neurotransmitter' gamma‑amino butyric acid (GABA), but has very different biological effects.
Maltese: Is-sustanza attiva f'Pregabalin Accord, il-pregabalina, hija simili fl-istruttura għall-aċidu butriku talgamma-amino (GABA) ‘newrotrażmettitur' tal-ġisem stess, iżda għandu effetti bijoloġiċi differenti ħafna.
English: Pregabalin Accord pregabalin
Maltese: Pregabalin Accord huwa
English: Pregabalin Accord contains the active substance pregabalin.
Maltese: Pregabalin Accord fih is-sustanza attiva pregabalina.
English: • neuropathic pain (pain due to nerve damage), including peripheral neuropathic pain, such as the pain experienced by patients with diabetes or herpes zoster (shingles), and central neuropathic pain, such as the pain experienced by patients who have had a spinal cord injury;
Maltese: • uġigħ newropatiku (uġigħ dovut għal ħsara fin-nervituri) inkluż uġigħ newropatiku periferiku, bħal uġigħ esperjenzat minn pazjenti b'dijabete jew li għandhom il-herpes zoster (ħruq ta' Sant'Antnin), u uġigħ newropatiku ċentrali, bħalma huwa uġigħ esperjenzat minn pazjenti li kellhom korriment fis-sinsla tad-dahar;
English: Other information about Pregabalin Accord
Maltese: Informazzjoni oħra dwar Pregabalin Accord
English: Neurotransmitters are chemicals that allow nerve cells to communicate with each other.
Maltese: In-newrotrażmettituri huma sustanzi kimiċi li jippermettu liċ-ċelloli tan-nervituri jikkomunikaw ma
English: After one week, the dose can be increased to 300 mg per day.
Maltese: Wara ġimgħa, id-doża tista' tiżdied għal 300 mg kuljum.
English: Because Pregabalin Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Maltese: Minħabba li Pregabalin Accord huwa mediċina ġenerika u huwa bijoekwivalenti għall-mediċina ta' referenza, il-benefiċċji u r-riskji tiegħu jitqiesu l-istess bħal dawk tal-mediċina ta' referenza.
English: EPAR summary for the public
Maltese: Sommarju tal-EPAR għall-pubbliku pregabalina
English: The recommended starting dose is 150 mg per day, divided into two or three doses.
Maltese: Id-doża inizjali rakkomandata hija ta' 150 mg kuljum, maqsuma f'żewġ dożi jew tlieta.
English: • epilepsy, where it is used as an ‘add-on' to other epilepsy treatment in patients who have partial seizures (epileptic fits starting in one specific part of the brain);
Maltese: • epilessija, fejn jintuża b ħala "żieda" flimki minn aċċessjonijiet parzjali (aċċessjonijiet epileptiċi li jibdew f'parti speċifika tal-moħħ); • disturb tal-ansjetà ġeneralizzat (ansjetà jew nervi fit-tul dwar kwistjonijiet ta
English: How does Pregabalin Accord work?
Maltese: ' Pregabalin Accord.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pregabalin Accord has been shown to have comparable quality and to be bioequivalent to Lyrica.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) tal-Aġenzija kkonkluda li, b'mod konformi mar-rekwiżiti tal-UE, Pregabalin Accord wera li għandu kwalità komparabbli u huwa bijoekwivalenti għal Lyrica.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pregabalin Accord on 28 August 2015.
Maltese: Il-Kumitat irrakkomanda li Pregabalin Accord ikun approvat għall-użu fl-UE.
English: Why is Pregabalin Accord approved?
Maltese: Għaliex ġie approvat Pregabalin Accord?
English: How has Pregabalin Accord been studied?
Maltese: Kif ġie studjat Pregabalin Accord ?
English: How is Pregabalin Accord used?
Maltese: Kif jintuża Pregabalin Accord?
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Lyrica, and do not need to be repeated for Pregabalin Accord.
Maltese: referenza, Lyrica, u ma għandhomx għalfejn jiġu ripetuti għal Pregabalin Accord.
English: Therefore, the CHMP's view was that, as for Lyrica, the benefit outweighs the identified risk.
Maltese: Għaldaqstant, il-fehma tas-CHMP kienet li, bħal fil-każ ta' Lyrica, ilbenefiċċju huwa akbar mir-riskju identifikat.
English: What are the benefits and risks of Pregabalin Accord?
Maltese: X'inhuma l-benefiċċji u r-riskji ta' Pregabalin Accord?
English: This means that Pregabalin Accord contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Lyrica.
Maltese: -istess sustanza attiva u jaħdem bl-istess mod b ħal ‘medi -Unjoni Ewropea (UE) msejħa Lyrica.
English: This reduces the activity of some of the nerve cells in the brain and spinal cord, reducing the release of other neurotransmitters that are involved in epilepsy and anxiety.
Maltese: Dan inaqqas l-attività ta' xi ċelloli tannervituri fil-moħħ u fis-sinsla tad-dahar, billi jnaqqas ir-rilaxx ta' newrotrażmettituri oħrajn li huma involuti fl-epilessija u l-ansjetà.
English: 448 (8x 56) capsules +10 inhalers (2 x monthly multipack)
Maltese: folja (alu/alu) 448 (8x 56) kapsula + +10 inhalers (2 pakketti b'ħafna għal xahar)
English: 224 (4x 56) capsules + 5 inhalers (monthly multipack)
Maltese: Daqs tal-pakkett folja (alu/alu) 56 kapsula + inhaler wieħed folja (alu/alu) 224 (4x 56) kapsula + 5 inhalers (pakkett b'ħafna għal xahar)
English: VIRBAC Sp. z o.o.
Maltese: VIRBAC Sp. z o.o. ul.
English: Puławska 314 02 - 819 Warszawa
Maltese: Puławska 314 02 - 819 Warszawa Polska
English: VIRBAC Nederland BV Hermesweg 15
Maltese: Nederland VIRBAC Nederland BV Hermesweg 15
English: VIRBAC Hungary KFT Szent Istvàn krt.11.II/21.
Maltese: HU: Magyarország VIRBAC Hungary KFT Szent Istvàn krt.11.II/21.
English: VIRBAC Österreich GmbH Hildebrandgasse 27
Maltese: Österreich VIRBAC Österreich GmbH Hildebrandgasse 27
English: ATC vet code: QP54AA05.
Maltese: QP54AA05
English: VIRBAC LTD Suffolk, IP30 9UP U.K.
Maltese: UK: United Kingdom VIRBAC LTD Suffolk, IP30 9UP U.K.
English: Active substance:
Maltese: Sustanza Attiva
English: VIRBAC Danmark A/S Profilvej 1 6000 Kolding Danmark
Maltese: VIRBAC Danmark A/S Profilvej 1 6000
English: VIRBAC Tierarzneimittel GmbH Rögen 20
Maltese: DE: Deutschland VIRBAC Tierarzneimittel GmbH Rögen 20
English: Αθηνών - Λαμίας, T.K.14452, Μεηαμόρθωζη, Ελλάδα
Maltese: VIRBAC Hellas SA 13o χλμ Ε.Ο. Αθηνών - Λαμίας, T.K.14452, Μεηαμόρθωζη, Ελλάδα
English: VIRBAC España SA Angel Guimerá 179-181 08950 Esplugues de Llobregat (Barcelona)
Maltese: VIRBAC España SA Angel Guimerá 179-181 08950
English: VIRBAC Belgium NV Esperantolaan 4
Maltese: BE: België/Belgique VIRBAC Belgium NV Esperantolaan 4
English: Polska Tel.: + 48 22 855 40 46
Maltese: Tel.: + 48 22 855 40 46
English: Method and route of administration:
Maltese: Metodu ta' amministrazzjoni:
English: Butylated hydroxytoluene 0.8 mg/ml.
Maltese: Ingredjenti Oħra: Butylated hydroxytoluene 0.8 mg/ml
English: 13e rue LID
Maltese: FR: France VIRBAC France 13e rue LID
English: 1 pipette 4 pipettes 24 pipettes x 0.75 ml x 1.0 ml
Maltese: 4 pipetti 24 pipetta x 0.75 ml x 1.0 ml
English: Administere d volume (nominal pipette size, ml)
Maltese: Volum amministrat (daqs nominali tal-pipetta, ml)
English: SK: Slovenská republika
Maltese: SK: Slovenská republika VIRBAC
English: 1 pipette 4 pipettes 24 pipettes x 0.25 ml x 0.5 ml x 1.0 ml x 2.0 ml x 3.0 ml
Maltese: Pipetti 24 Pipetta x 0.25 ml x 0.5 ml x 1.0 ml x 2.0 ml x 3.0 ml
English: 60 mg
Maltese: Selamektin 60 mg
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: Il-frekwenza ta' effetti mhux mixtieqa hija definita skont din il-konvenzjoni: - komuni ħafna (aktar minn wieħed f'10 annimali ttrattati li juru effetti mhux mixtieqa - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal ittrattat) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimalttrattat ) - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimalttrattati ) - rari ħafna (inqas minn annimal wieħed f'10,000 annima ilttrattati , inklużi rapporti iżolati).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON 30mg, 60mg, 120mg, 240mg, 360mg (1, 4 AND 24 PIPETTES)
Maltese: TIKKETTA TAL-KAXXA 30 mg, 60 mg, 120 mg, 240 mg, 360 mg (1, 4 U 24 PIPETTA)
English: DK: Danmark
Maltese: Kolding Danmark
English: FI: Suomi/Finland
Maltese: Suomi/Finland VIRBAC
English: 30 mg
Maltese: Selamektin 30 mg
English: Spot-on use.
Maltese: Użu topikali.
English: Activity has also been demonstrated against heartworm larvae.
Maltese: Instab ukoll li jkun hemm effett kontra l- larvi tal-heartworm.
English: No undesirable effects were observed after the administration of 10 times the recommended dose of selamectin.
Maltese: Ma ġewx osservati effetti mhux mixtieqa wara l-amministrazzjoni ta' 10 darbiet iżjed id-doża rikkomandata ta' selamectin. .
English: 45 mg
Maltese: Selamektin 45 mg
English: This product is not effective against adult D. immitis.
Maltese: Dan ilprodott ma jaħdimx kontra l-forma adulta tad-D. immitis.
English: The product is available in packs of one, four and twenty-four pipettes (all pipette sizes).
Maltese: Il-prodott jinstab f'pakketti ta' 1, 4 u 24 pipetta (id-daqsijiet kollha).
English: VIRBAC France
Maltese: Република България VIRBAC
English: Evicto 45 mg spot-on solution for cats 2.6-7.5 kg Evicto 60 mg spot-on solution for cats 7.6-10.0 kg selamectin
Maltese: Evicto 45 mg soluzzjoni għal użu topikali għall-qtates 2.6-7.5 kg Evicto 60 mg soluzzjoni għal użu topikali għall-qtates 7.6-10.0 kg Selamektin
English: 40.1-60.0 1 pipette of Evicto 360 mg for dogs 40.1-60.0 kg
Maltese: 1-40.0 kg EVICTO 360 mg soluzzjoni għal użu topikali għall-klieb 40.1-60.0 kg
English: 1 pipette of EVICTO 15 mg for cats and dogs contains 0.25 ml of 60 mg/ml solution 1 pipette of EVICTO 45 mg for cats contains 0.75 ml of 60 mg/ml solution 1 pipette of EVICTO 60 mg for cats contains 1.0 ml of 60 mg/ml solution 1 pipette of EVICTO 30 mg for dogs contains 0.25 ml of 120 mg/ml solution 1 pipette of EVICTO 60 mg for dogs contains 0.5 ml of 120 mg/ml solution 1 pipette of EVICTO 120 mg for dogs contains 1.0 ml of 120 mg/ml solution 1 pipette of EVICTO 240 mg for dogs contains 2.0 ml of 120 mg/ml solution 1 pipette of EVICTO 360 mg for dogs contains 3.0 ml of 120 mg/ml solution.
Maltese: Pipetta ta' EVICTO 15 mg għal qtates u klieb fiha 0.25 ml ta' soluzzjoni 60 mg/ml Pipetta ta' EVICTO 45 mg għal qtates fiha 0.75 ml ta' soluzzjoni 60 mg/ml Pipetta ta' EVICTO 60 mg għal qtates fiha 1.0 ml ta' soluzzjoni 60 mg/ml Pipetta ta' EVICTO 30 mg għal klieb fiha 0.25 ml ta' soluzzjoni 120 mg/ml Pipetta ta' EVICTO 60 mg għal klieb fiha 0. 5 ml ta' soluzzjoni 120 mg/ml Pipetta ta' EVICTO 120 mg għal klieb fiha 1.0 ml ta' soluzzjoni 120 mg/ml Pipetta ta' EVICTO 240 mg għal klieb fiha 2.0 ml ta' soluzzjoni 120 mg/ml Pipetta ta' EVICTO 360 mg għal klieb fiha 3.0 ml ta' soluzzjoni 120 mg/ml
English: The prolonged persistence and slow elimination of selamectin from plasma is reflected in the terminal elimination half-life values of 8 and 11 days in cats and dogs respectively.
Maltese: Il-persistenza fit-tul tas-selamektin u leliminazzjoni mid-demm bil-mod huma riflessi f'valuri tat-terminal elimination half-life ta' tmien tijiem fil-qtates u ħdax-il jum fil-klieb.
English: 7.6-10.0 1 pipette of Evicto 60 mg for cats 7.6-10.0kg
Maltese: Pipetta waħda ta' EVICTO 60 mg għal qtates 7.6-10 kg
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Sachets 15mg, 30mg, 45mg, 60mg, 120mg, 240mg, 360mg,
Maltese: TIKKETTA FUQ IL-FOLJA, 15 mg, 30 mg, 45 mg, 60 mg, 120 mg, 240 mg, 360 mg
English: CZ: Česká republika
Maltese: Česká republika VIRBAC
English: Date of first authorisation: 19 July 2019
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI / TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni 19/07/2019
English: 1 - Holding the pipette upright, remove the cap.
Maltese: 1 - Filwaqt li żżomm il-pipetta wieqfa, neħħi t-tapp.
English: ≤ 2.5 1 pipette of Evicto 15 mg for cats and dogs ≤2.5 kg 2.6-7.5 1 pipette of Evicto 45 mg for cats 2.6-7.5 kg
Maltese: Pipetta waħda ta' EVICTO 15 mg għal qtates u klieb ≤2.5 kg 2.6-7.5 Pipetta waħda ta' EVICTO 45 mg għal qtates 2.6-7.5 kg 7.6-10.0
English: VIRBAC Hellas SA
Maltese: Għal użu topikali
English: Spot-on use
Maltese: NUMRU TAL-LOTT
English: Evicto 15 mg spot-on solution for cats and dogs ≤2.5 kg selamectin
Maltese: Evicto 15 mg soluzzjoni għal użu topikali għall-qtates u klieb ≤2.5 kg Selamektin
English: EVICTO 240 mg for dogs
Maltese: Selamektin 240 mg
English: Cat, dog
Maltese: Qtates, klieb
English: • Treatment of adult intestinal roundworms (Toxocara canis).
Maltese: • Kura għall-forma adulta tal-ħniex todi (Toxocara canis) fl-imsaren.
English: Evicto 120 mg spot-on solution for dogs 10.1-20.0 kg Evicto 240 mg spot-on solution for dogs 20.1-40.0 kg Evicto 360 mg spot-on solution for dogs 40.1-60.0 kg selamectin
Maltese: 1-20.0 kg Evicto 240 mg soluzzjoni għal użu topikali għall-klieb 20.1-40.0 kg Evicto 360 mg soluzzjoni għal użu topikali għall-klieb 40.
English: 60 mg/ml solution Selamectin 60 mg
Maltese: Evicto 60 mg għall-qtates soluzzjoni 60 mg/ml
English: EU/2/19/242/010 EU/2/19/242/011 EU/2/19/242/012
Maltese: EU/2/19/242/011 EU/2/19/242/012
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Maltese: Ħtiġijiet ta' farmakoviġilanza:
English: If significant licking does occur, a brief period of hypersalivation may rarely be observed in cats.
Maltese: Jekk l-annimal xorta jilgħaqu, fil-qtates jista jiġi rarament osservat perjodu qasir ta' ipersalivazzjoni.
English: Butylhydroxytoluene 0.8 mg/ml For the full list of excipients, see section 6.1.
Maltese: Għal-lista sħiħa tal-ingredjenti (mhux attivi), ara s-sezzjoni 6.1.
English: EU/2/19/242/013 EU/2/19/242/014 EU/2/19/242/015
Maltese: EU/2/19/242/013 EU/2/19/242/014
English: EU/2/19/242/016 EU/2/19/242/017 EU/2/19/242/018
Maltese: EU/2/19/242/017 EU/2/19/242/018
English: 1 pipette of Evicto 15 mg for cats and dogs ≤2.5 kg 2.6-5.0 1 pipette of Evicto 30 mg for dogs 2.6-5.0 kg
Maltese: EVICTO 15 mg għal qtates u klieb ≤2.5 kg 2.6-5.0
English: 120 mg/ml solution Selamectin 120 mg
Maltese: Evicto 120 mg għall-klieb soluzzjoni 120 mg/ml
English: Evicto 360 mg for dogs
Maltese: Selamektin 360 mg
English: Treatment of biting lice infestations (Felicola subrostratus) Treatment of adult roundworms (Toxocara cati) Treatment of adult intestinal hookworms (Ancylostoma tubaeforme).
Maltese: Persuni b'ġilda sensittiva jew b'allerġija magħrufa għall-prodotti mediċinali veterinarji ta' dan it-tip għandhom joqgħodu attenti meta jmissu l-prodott mediċinali veterinarju.
English: Evicto 15 mg spot-on solution for cats and dogs ≤ 2.5 kg Evicto 30 mg spot-on solution for dogs 2.6-5.0 kg Evicto 45 mg spot-on solution for cats 2.6-7.5 kg Evicto 60 mg spot-on solution for cats 7.6-10.0 kg Evicto 60 mg spot-on solution for dogs 5.1-10.0 kg Evicto 120 mg spot-on solution for dogs 10.1-20.0 kg Evicto 240 mg spot-on solution for dogs 20.1-40.0 kg Evicto 360 mg spot-on solution for dogs 40.1-60.0 kg selamectin
Maltese: Evicto 15 mg soluzzjoni għal użu topikali għall-qtates u l-klieb ≤ 2.5 kg Evicto 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg Evicto 45 mg soluzzjoni għal użu topikali għall-qtates 2.6-7.5 kg Evicto 60 mg soluzzjoni għal użu topikali għall-qtates 7.6-10.0 kg Evicto 60 mg soluzzjoni għal użu topikali għall-klieb 5.1-10.0 kg Evicto 120 mg soluzzjoni għal użu topikali għall-klieb 10.
English: 2.6-5.0 1 pipette of Evicto 30 mg for dogs 2.6-5.0 kg 5.1-10.0 1 pipette of Evicto 60 mg for dogs 5.1-10.0 kg 10.1-20.0 1 pipette of Evicto 120 mg for dogs 10.1-20.0 kg
Maltese: EVICTO 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg EVICTO 60 mg soluzzjoni għal użu topikali għall-klieb 5.1-10.0 kg EVICTO 120 mg soluzzjoni għal użu topikali għall-klieb 10.
English: EU/2/19/242/019 EU/2/19/242/020 EU/2/19/242/021
Maltese: EU/2/19/242/019 EU/2/19/242/020
English: Mg of selamectin dispensed
Maltese: Klieb (kg) Prodott mg ta' selamektin mogħtija